Is IQVIA Holdings (IQV) a Good Long-Term Investment Choice?

Investment management company Ave Maria recently released its “Ave Maria World Equity Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. At the end of the second quarter, the fund returned -14.19% compared to -15.66% for MSCI All Country World Index. Poor performance of large global markets affected the fund’s performance. You can check the top 5 holdings of the fund to know its best picks in 2022.

Ave Maria discussed stocks like IQVIA Holdings Inc. (NYSE:IQV) in the second quarter investor letter. Headquartered in Durham, North Carolina, IQVIA Holdings Inc. (NYSE:IQV) is a company that provides health information technology and clinical research services. On August 24, 2022, IQVIA Holdings Inc. (NYSE:IQV) stock closed at $231.83 per share. One-month return of IQVIA Holdings Inc. (NYSE:IQV) was -1.77% and its shares lost 10.31% of their value over the last 52 weeks. IQVIA Holdings Inc. (NYSE:IQV) has a market capitalization of $43.238 billion.

Here is what Ave Maria specifically said about IQVIA Holdings Inc. (NYSE:IQV):

“IQVIA Holdings Inc. (NYSE:IQV) offers data solutions and clinical research services to life science companies. Approximately half of IQVIA’s revenue comes from its contract research organization (CRO), which provides support to the pharmaceutical and biotechnology industries in the form of research services outsourced on a contract basis. IQVIA continues to win new contracts and grew its backlog to almost $25 billion.”

Pressmaster/Shutterstock.com

IQVIA Holdings Inc. (NYSE:IQV) is not on the list of 30 Most Popular Stocks Among Hedge Funds. IQVIA Holdings Inc. (NYSE:IQV) was held by 53 hedge fund portfolios at the end of the second quarter compared to 62 in the previous quarter.

We discussed IQVIA Holdings Inc. (NYSE:IQV) in another article and shared Cooper Investors’ views on the company. You can check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other prominent investors.

Disclosure: None. This article is originally published at Insider Monkey.